These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 20422780)

  • 1. Aldosterone and inflammation.
    Gilbert KC; Brown NJ
    Curr Opin Endocrinol Diabetes Obes; 2010 Jun; 17(3):199-204. PubMed ID: 20422780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis.
    Brown NJ
    Nat Rev Nephrol; 2013 Aug; 9(8):459-69. PubMed ID: 23774812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldosterone in vascular and metabolic dysfunction.
    Luther JM
    Curr Opin Nephrol Hypertens; 2016 Jan; 25(1):16-21. PubMed ID: 26575396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldosterone and end-organ damage.
    Brown NJ
    Curr Opin Nephrol Hypertens; 2005 May; 14(3):235-41. PubMed ID: 15821416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells.
    Jaffe IZ; Mendelsohn ME
    Circ Res; 2005 Apr; 96(6):643-50. PubMed ID: 15718497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mineralocorticoid receptor and oxidative stress.
    Fiebeler A; Luft FC
    Heart Fail Rev; 2005 Jan; 10(1):47-52. PubMed ID: 15947891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone.
    Keidar S; Kaplan M; Pavlotzky E; Coleman R; Hayek T; Hamoud S; Aviram M
    Circulation; 2004 May; 109(18):2213-20. PubMed ID: 15123520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new HOPE for aldosterone blockade?
    Pitt B
    Circulation; 2004 Sep; 110(13):1714-6. PubMed ID: 15451807
    [No Abstract]   [Full Text] [Related]  

  • 9. Aldosterone, mineralocorticoid receptors, and vascular inflammation.
    Fiebeler A; Muller DN; Shagdarsuren E; Luft FC
    Curr Opin Nephrol Hypertens; 2007 Mar; 16(2):134-42. PubMed ID: 17293689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldosterone and Mineralocorticoid Receptor Signaling as Determinants of Cardiovascular and Renal Injury: From Hans Selye to the Present.
    Epstein M
    Am J Nephrol; 2021; 52(3):209-216. PubMed ID: 33857953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrarenal effects of aldosterone.
    Nguyen Dinh Cat A; Jaisser F
    Curr Opin Nephrol Hypertens; 2012 Mar; 21(2):147-56. PubMed ID: 22240440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease?
    Bender SB; McGraw AP; Jaffe IZ; Sowers JR
    Diabetes; 2013 Feb; 62(2):313-9. PubMed ID: 23349535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aldosterone and cardiovascular disease.
    Carey RM
    Curr Opin Endocrinol Diabetes Obes; 2010 Jun; 17(3):194-8. PubMed ID: 20422779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. This is not Dr. Conn's aldosterone anymore.
    Brown NJ
    Trans Am Clin Climatol Assoc; 2011; 122():229-43. PubMed ID: 21686229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldosterone synthase inhibitors in cardiovascular and renal diseases.
    Namsolleck P; Unger T
    Nephrol Dial Transplant; 2014 Feb; 29 Suppl 1():i62-i68. PubMed ID: 24493871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone Synthase in Peripheral Sensory Neurons Contributes to Mechanical Hypersensitivity during Local Inflammation in Rats.
    Mohamed DM; Shaqura M; Li X; Shakibaei M; Beyer A; Treskatsch S; Schäfer M; Mousa SA
    Anesthesiology; 2020 Apr; 132(4):867-880. PubMed ID: 32011337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldosterone and its blockade: a cardiovascular and renal perspective.
    Lahera V; Cachofeiro V; Balfagon G; Rodicio JL
    ScientificWorldJournal; 2006 Apr; 6():413-24. PubMed ID: 16604252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitigating risk of aldosterone in diabetic kidney disease.
    Frimodt-Møller M; Persson F; Rossing P
    Curr Opin Nephrol Hypertens; 2020 Jan; 29(1):145-151. PubMed ID: 31599747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new look at the eye: aldosterone and mineralocorticoid receptors as novel targets in retinal vasculopathy.
    Touyz RM; Callera GE
    Circ Res; 2009 Jan; 104(1):9-11. PubMed ID: 19118282
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of aldosterone and mineralocorticoid receptors in cardiovascular disease.
    Funder JW
    Am J Cardiovasc Drugs; 2007; 7(3):151-7. PubMed ID: 17610342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.